Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 4:03 AM
Study NCT ID:
NCT00633594
Status:
COMPLETED
Last Update Posted:
2017-01-31
First Post:
2008-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2015-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-04
First Submit QC Date:
None
Study First Post Date:
2008-03-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-19
Results First Submit QC Date:
None
Results First Post Date:
2017-01-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-06
Last Update Post Date:
2017-01-31
Last Update Post Date Type:
ESTIMATED